BRAF-mutation-mediated MAPK pathway downstream was often constitutively activated and led to cancer cell differentiation, proliferation, angiogenesis, and anti-apoptosis, suggesting targeting the BRAF pathway might inhibit HCC progression in the future (Gnoni et al., 2019). This evidence concerns the gene BRAF and cancer.